🇺🇸 clofibrate clofibrate in United States

8 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 8

Most-reported reactions

1. Blood Creatinine Increased — 1 report (12.5%)
2. Blood Urea Increased — 1 report (12.5%)
3. Decreased Appetite — 1 report (12.5%)
4. Diarrhoea — 1 report (12.5%)
5. Hypotension — 1 report (12.5%)
6. Incorrect Dose Administered — 1 report (12.5%)
7. Nausea — 1 report (12.5%)
8. Vomiting — 1 report (12.5%)

Source database →

Frequently asked questions

Is clofibrate clofibrate approved in United States?

clofibrate clofibrate does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for clofibrate clofibrate in United States?

National Heart, Lung, and Blood Institute (NHLBI) is the originator. The local marketing authorisation holder may differ — check the official source linked above.